Radiobiological Evaluation of Intensity Modulated Radiotherapy Treatment for Locally Advanced Head and Neck Squamous Cell Carcinomas

被引：0
|
作者：
Reddy, B. Rekha
Ravikumar, M.
Pasha, C. R. Tanvir
Kumar, M. R. Anil
Pyakuryal, A.
Varatharaj, C.
Narayanasamy, Ganesh
机构：
来源：
MEDICAL PHYSICS | 2014年 / 41卷 / 06期
关键词：
Cancer; Intensity modulated radiation therapy; Radiation treatment; Dosimetry; Chemotherapy; Tissues; Photons; Quantum optics;
D O I：
10.1118/1.4888606
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
SU-E-T-275
引用
收藏
页码：287 / +
页数：2
相关论文
共 50 条
  • [21] Emerging Therapies in the Treatment of Locally Advanced Squamous Cell Cancers of Head and Neck
    Raza, Shahzad
    Kornblum, Noah
    Kancharla, Venkat P.
    Baig, Mahadi A.
    Singh, Amrit B.
    Kalavar, Madhumati
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2011, 6 (02) : 246 - 257
  • [22] Can Intensity-Modulated-Radiotherapy Reduce Toxicity in Head and Neck Squamous Cell Carcinoma?
    van der Veen, Julie
    Nuyts, Sandra
    CANCERS, 2017, 9 (10)
  • [23] Induction chemotherapy in locally advanced squamous cell carcinoma of the head and neck
    Okano, Susumu
    Homma, Akihiro
    Kiyota, Naomi
    Tahara, Makoto
    Hanai, Nobuhiro
    Asakage, Takahiro
    Matsuura, Kazuto
    Ogawa, Takenori
    Saito, Yuki
    Sano, Daisuke
    Kodaira, Takeshi
    Motegi, Atsushi
    Yasuda, Koichi
    Takahashi, Shunji
    Tanaka, Kaoru
    Onoe, Takuma
    Yokota, Tomoya
    Imamura, Yoshinori
    Ariizumi, Yosuke
    Akimoto, Tetsuo
    Hayashi, Ryuichi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2021, 51 (02) : 173 - 179
  • [24] Induction Therapy for Locally Advanced Head and Neck Squamous Cell Carcinoma
    Zheng, Shuwen
    Feng, Yumei
    Li, Chan
    Zhang, Jie
    Xie, Ke
    ONCOLOGY AND THERAPY, 2023, 11 (02) : 185 - 198
  • [25] Three-dimensional conformal radiotherapy versus intensity modulated radiotherapy with simultaneous integrated boost in the treatment of locally advanced head and neck carcinoma
    Jirkovska, M.
    Novak, T.
    Malinova, B.
    Lohynska, R.
    NEOPLASMA, 2019, 66 (05) : 830 - 838
  • [26] Patterns of relapse following definitive treatment of head and neck squamous cell cancer by intensity modulated radiotherapy and weekly cisplatin
    Loimu, Venla
    Collan, Juhani
    Vaalavirta, Leila
    Back, Leif
    Kapanen, Mika
    Makitie, Antti
    Tenhunen, Mikko
    Saarilahti, Kauko
    RADIOTHERAPY AND ONCOLOGY, 2011, 98 (01) : 34 - 37
  • [27] CHRONOMODULATED CHEMOTHERAPY AND CONCOMITANT RADIOTHERAPY, FOR THE MANAGEMENT OF LOCALLY ADVANCED, HEAD AND NECK SQUAMOUS CELL CARCINOMA
    Verma, Yashpal
    Chauhan, Ashok K.
    Singh, Harmeet
    Sabharwal, Ramesh
    Bharti, Mukesh
    Kaur, Paramjeet
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2014, 5 (03): : 1015 - 1022
  • [28] Treatment of locally advanced carcinomas of head and neck with intensity-modulated radiation therapy (IMRT) in combination with cetuximab and chemotherapy: the REACH protocol
    Habl, Gregor
    Jensen, Alexandra D.
    Potthoff, Karin
    Uhl, Matthias
    Hof, Holger
    Hajda, Jacek
    Simon, Christian
    Debus, Juergen
    Krempien, Robert
    Muenter, Marc W.
    BMC CANCER, 2010, 10
  • [29] Durvalumab with cetuximab and radiotherapy for locally advanced squamous cell carcinoma of the head and neck: A phase 1/2 trial
    Bonomo, Pierluigi
    Desideri, Isacco
    Mangoni, Monica
    Saieva, Calogero
    Loi, Mauro
    Becherini, Carlotta
    Cerbai, Cecilia
    Ganovelli, Michele
    Salvestrini, Viola
    Stocchi, Giulia
    Zani, Margherita
    Palomba, Annarita
    Livi, Lorenzo
    RADIOTHERAPY AND ONCOLOGY, 2022, 169 : 64 - 70
  • [30] Feasibility of radiotherapy or chemoradiotherapy after taxane-based induction chemotherapy for nonoperated locally advanced head and neck squamous cell carcinomas
    Levy, Antonin
    Blanchard, Pierre
    Bellefqih, Sara
    Brahimi, Nacera
    Guigay, Joel
    Janot, Franois
    Temam, Stephane
    Daly-Schveitzer, Nicolas
    Bourhis, Jean
    Tao, Yungan
    ANTI-CANCER DRUGS, 2014, 25 (10) : 1220 - 1226
12345